NICOX
DEAD

Serial Number

97574828

Owner

NICOX SA

Attorney

John Zaccaria

Filing Date

Sep 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NICOX Trademark

Serial Number: 97574828

NICOX is a trademark filed by NICOX SA on September 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NICOX SA (24 trademarks)

Taissounières HB4 1681 Route des Dolines
Valbonne 06560 , FR

Entity Type: 99

Trademark Details

Filing Date

September 1, 2022

Registration Date

Not Registered

Published for Opposition

July 25, 2023

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Dietetic foods adapted for medical use, namely, meal replacement bars, meal replacement drink mixes, minerals, vitamins

Online retail and wholesale store services featuring pharmaceutical products, dietary supplements, dietetic substances adapted for medical use, medical apparatus and instruments, and diagnostic apparatus for medical purposes

Medical evaluation services in the fields of ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, and burns, for purposes of guiding treatment

Medical apparatus and instruments for use in the treatment of ocular and ophthalmological disease, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous systems disease, musculoskeletal systems disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Diagnostic apparatus for medical purposes for detecting ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 22, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 22, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2023 CNSA
ASSIGNED TO EXAMINER
Jun 17, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2022 NWOS
NEW APPLICATION ENTERED
Sep 5, 2022 NWAP